ImpriMed
AI-driven Personalized Medicine for Cancer Care
馃嚭馃嚫 Palo Alto, CA, United States 路 Biotech 路 Seed; Series A
AI-powered drug response prediction for pet cancer
Backed by
Pear VC
Total tracked
-
Open roles
0
How to stand out for ImpriMed
Talent Graph
Apply with your Role Readiness, not just a resume.
Role Readiness is a 0-100 score for your target role, built only from proof - certifications, cleared simulations, ranked projects. It shows a recruiter what you can actually do, in one link, before any interview.
About ImpriMed
ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company鈥檚 pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company鈥檚 technology has been deployed across more than 45 U.S. states, and 27,000+ canine and feline blood cancer tests have been performed as of 2026.
ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.
Open roles
0 listed 路 tech, AI & dataNo open tech roles right now.
We re-check their careers page regularly - follow to get notified.
Talent snapshot
Employee functions
Employee locations
Common skills